Robinson, Carl – Trademark Portfolio
Entity Type: 01
Robinson, Carl owns a portfolio of 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as THYROTECT, HERBOTHECARY, and CEDAR BEAR NATURALES. Of these, 3 are registered. The portfolio spans 7 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 25 (Clothing). Headquartered in Ballard, UT.
1047 U.S. Hwy 40
Ballard, UT 84066
Showing of trademarks Trademarks
Trademark Classifications
Robinson, Carl's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Robinson, Carl have?
Robinson, Carl has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 abandoned.
What trademark classes does Robinson, Carl file in?
Robinson, Carl files trademarks across 7 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 35 (Advertising & Business), Class 16 (Paper Goods), Class 38 (Telecommunications). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Robinson, Carl's most well-known trademarks?
Robinson, Carl's registered trademark portfolio includes well-known marks such as THYROTECT, HERBOTHECARY, and CEDAR BEAR NATURALES. These are among 3 currently registered trademarks in the portfolio.
What is Robinson, Carl's trademark registration success rate?
Robinson, Carl has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.